Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Clovis Oncology to Announce Second Quarter 2013 Financial Results and Host Webcast Conference Call on August 1



  Clovis Oncology to Announce Second Quarter 2013 Financial Results and Host
  Webcast Conference Call on August 1

Business Wire

BOULDER, Colo. -- July 24, 2013

Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its second quarter 2013
financial results on Thursday, August 1, 2013, before the open of the U.S.
financial markets. Clovis’ senior management will host a conference call and
live audio webcast on Thursday, August 1, at 8:30 a.m. ET to discuss the
company’s results in greater detail.

The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com. A replay of the webcast will be
available for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado, and has additional offices in San
Francisco, California and Cambridge, UK.

Contact:

Clovis Oncology
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement